Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial

被引:50
作者
Sargent, A.
Bailey, A.
Turner, A.
Almonte, M. [4 ]
Gilham, C. [5 ]
Baysson, H. [6 ]
Peto, J. [6 ]
Roberts, C. [2 ]
Thomson, C. [3 ]
Desai, M. [1 ]
Mather, J. [1 ]
Kitchener, H. [3 ]
机构
[1] Univ Manchester, Manchester Cytol Ctr, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9PL, Lancs, England
[3] Univ Manchester, Sch Canc & Imaging Sci, Manchester M13 9PL, Lancs, England
[4] Queen Mary Univ London, Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London, England
[5] Inst Canc Res, London SW3 6JB, England
[6] London Sch Hyg & Trop Med, London WC1, England
关键词
GRADE CERVICAL LESIONS; NATURAL-HISTORY; INFECTION; CANCER; ASSAY; RISK; WOMEN; CELL; PCR;
D O I
10.1128/JCM.00896-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We present data on the use of the Hybrid Capture 2 (HC2) test for the detection of high-risk human papillomavirus (HR HPV) with different thresholds for positivity within a primary screening setting and as a method of triage for low-grade cytology. In the ARTISTIC population-based trial, 18,386 women were screened by cytology and for HPV. Cervical intraepithelial neoplasia lesions of grade two and higher (CIN2+ lesions) were identified for 453 women within 30 months of an abnormal baseline sample. When a relative light unit/cutoff (RLU/Co) ratio of >= 1 was used as the threshold for considering an HC2 result positive, 15.6% of results were positive, and the proportion of CIN2+ lesions in this group was 14.7%. The relative sensitivity for CIN2+ lesion detection was 93.4%. When an RLU/Co ratio of +/- 2 was used as the threshold, there was a 2.5% reduction in positivity, with an increase in the proportion of CIN2+ lesions detected. The relative sensitivity decreased slightly, to 90.3%. Among women with low-grade cytology, HPV prevalences were 43.7% and 40.3% at RLU/Co ratios of >= 1 and >= 2, respectively. The proportions of CIN2+ lesions detected were 17.3% and 18.0%, with relative sensitivities of 87.7% at an RLU/Co ratio of >= 1 and 84.2% at an RLU/Co ratio of >= 2. At an RLU/Co ratio of >= 1,68.3% of HC2-positive results were confirmed by the Roche line blot assay, compared to 77.2% of those at an RLU/Co ratio of >= 2. Fewer HC2-positive results were confirmed for 35- to 64-year-olds (50.3% at an RLU/Co ratio of >= 1 and 63.2% at an RLU/Co ratio of >2) than for 20- to 34-year-olds (78.7% at an RLU/Co ratio of >= 1 and 83.7% at an RLU/Co ratio of >2). If the HC2 test is used for routine screening as an initial test or as a method of triage for low-grade cytology, we would suggest increasing the threshold for positivity from the RLU/Co ratio of >= 1, recommended by the manufacturer, to an RLU/Co ratio of >= 2, since this study has shown that a beneficial balance between relative sensitivity and the proportion of CIN21 lesions detected is achieved at this threshold.
引用
收藏
页码:554 / 558
页数:5
相关论文
共 17 条
[1]   Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: A longitudinal study of 3,091 women [J].
Bory, JP ;
Cucherousset, J ;
Lorenzato, M ;
Gabriel, R ;
Quereux, C ;
Birembaut, P ;
Clavel, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) :519-525
[2]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[3]  
Castle PE, 2002, CANCER EPIDEM BIOMAR, V11, P1394
[4]   Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study [J].
Castle, Philip E. ;
Gravitt, Patti E. ;
Solomon, Diane ;
Wheeler, Cosette M. ;
Schiffman, Mark .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) :109-117
[5]   Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women [J].
Clavel, C ;
Masure, L ;
Bory, JP ;
Putaud, I ;
Mangeonjean, C ;
Lorenzato, M ;
Nazeyrollas, P ;
Gabriel, R ;
Quereux, C ;
Birembaut, P .
BRITISH JOURNAL OF CANCER, 2001, 84 (12) :1616-1623
[6]   Natural history of cervicovaginal papillomavirus infection in young women [J].
Ho, GYF ;
Bierman, R ;
Beardsley, L ;
Chang, CJ ;
Burk, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :423-428
[7]   HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial [J].
Kitchener, Henry C. ;
Almonte, Maribel ;
Thomson, Claire ;
Wheeler, Paula ;
Sargent, Alexandra ;
Stoykova, Boyka ;
Gilham, Clare ;
Baysson, Helene ;
Roberts, Christopher ;
Dowie, Robin ;
Desai, Mina ;
Mather, Jean ;
Bailey, Andrew ;
Turner, Andrew ;
Moss, Sue ;
Peto, Julian .
LANCET ONCOLOGY, 2009, 10 (07) :672-682
[8]   Evaluation of human papillomavirus testing in primary screening for cervical abnormalities - Comparison of sensitivity, specificity, and frequency of referral [J].
Kulasingam, SL ;
Hughes, JP ;
Kiviat, NB ;
Mao, C ;
Weiss, NS ;
Kuypers, JM ;
Koutsky, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1749-1757
[9]   Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools [J].
Kulmala, SM ;
Syrjänen, S ;
Shabalova, I ;
Petrovichev, N ;
Kozachenko, V ;
Podistov, J ;
Ivanchenko, O ;
Zakharenko, S ;
Nerovjna, R ;
Kljukina, L ;
Branovskaja, M ;
Grunberga, V ;
Juschenko, A ;
Tosi, P ;
Santopietro, R ;
Syrjänen, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2470-2475
[10]   Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies [J].
Peyton, CL ;
Schiffman, M ;
Lörincz, AT ;
Hunt, WC ;
Mielzynska, I ;
Bratti, C ;
Eaton, S ;
Hildesheim, A ;
Morera, LA ;
Rodriguez, AC ;
Herrero, R ;
Sherman, ME ;
Wheeler, CM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) :3248-3254